Quick Answer
Korro Bio, Inc. reported Total Assets of $113.51 million for fiscal year 2025.
Korro Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $113.51M | -49.8% |
| 2024 | $226.24M | +2.1% |
| 2023 | $221.66M | +200.6% |
| 2022 | $73.74M | -60.2% |
| 2021 | $185.36M | -30.0% |
| 2020 | $264.72M | +18.6% |
| 2019 | $223.22M | +401.1% |
| 2018 | $44.55M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $161.55M | -33.7% | -10.5% |
| June 30, 2025 | $180.43M | -27.7% | -10.8% |
| March 31, 2025 | $202.21M | +2.1% | -10.6% |
| December 31, 2024 | $226.24M | +2.1% | -7.1% |
| September 30, 2024 | $243.54M | +425.5% | -2.4% |
| June 30, 2024 | $249.59M | +214.4% | +26.1% |
| March 31, 2024 | $197.99M | +95.1% | -10.7% |
| December 31, 2023 | $221.66M | +82.8% | +378.2% |
- Korro Bio, Inc. showed a decrease of -49.8% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Korro Bio, Inc.’s total assets has grown by 154.8% (from $44.55 million to $113.51 million).
- The most recent figure is from Korro Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: